Who owns Bharat Serums and Vaccines?
Bharat Serums and Vaccines is owned by Mankind Pharma (India, NSE: MANKIND), which has owned the brand since 23 October 2024.[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Mankind Pharma Limited Annual Report 2025-26. Last checked .
Key facts
- Current owner
- Mankind Pharma Limited reported
- Owned since
- Owner HQ
- 🇮🇳 India, New Delhi
- Origin
- 🇮🇳 India
- Category
- Healthcare & pharma › Drug makers › Biotechnology
- Parent ticker
- NSE: MANKIND BSE: 543904
- Last verified
- · 1 sources
About Bharat Serums and Vaccines
Bharat Serums and Vaccines makes biological medicines for women's health, fertility and critical care, including a recombinant anti-D immunoglobulin, the fertility hormone Foligraf and a polyvalent snake venom antiserum. Mankind Pharma completed its purchase of all of the company on 23 October 2024 for ₹13,768 crore, mainly from funds managed by Advent International, under an agreement signed on 25 July 2024.
Ownership timeline of Bharat Serums and Vaccines
- 2024 – present Mankind Pharma [1] reported
Where Bharat Serums and Vaccines sits in Mankind Pharma
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Mankind Pharma ownership tree →
See the full Mankind Pharma brand portfolio (6) →
Other brands owned by Mankind Pharma
Mankind Pharma controls 6 brands on Brandtree, 3 of them in healthcare & pharma.
Also in healthcare & pharma
Other brands in biotechnology, and who owns them
The 8 brands in biotechnology on Brandtree belong to 3 owners. The largest is Gilead, with 5.
About the owner: Mankind Pharma
Mankind Pharma is a publicly listed company headquartered in New Delhi, India, founded in 1991. Brandtree records 6 brands under its control, and it is listed as NSE: MANKIND and BSE: 543904.
Mankind Pharma is a New Delhi drug maker incorporated in 1991 that began operating in 1995 and listed on the Indian exchanges in May 2023. Revenue from operations was ₹14,278 crore in 2025-26. Besides prescription medicines it runs a consumer healthcare business through the wholly owned Mankind Consumer Products, which it entered between 2007 and 2010 with Manforce and Prega News. In October 2024 it bought all of Bharat Serums and Vaccines for ₹13,768 crore.
Mankind Pharma: full profile, brands and acquisition history →
🇮🇳 Bharat Serums and Vaccines and other Indian brands
Brandtree records a controlling owner for 279 brands that began in India. 9 of them (3%) are now controlled by a company headquartered in another country; Bharat Serums and Vaccines is not one of them.
Frequently asked questions
Who is the parent company of Bharat Serums and Vaccines?
The parent company of Bharat Serums and Vaccines is Mankind Pharma, a publicly listed company headquartered in India.
Is Bharat Serums and Vaccines Indian?
Yes. Bharat Serums and Vaccines originated in India and its owner, Mankind Pharma, is also headquartered in India.
Since when has Mankind Pharma owned Bharat Serums and Vaccines?
Mankind Pharma has owned Bharat Serums and Vaccines since 23 October 2024.
Is Bharat Serums and Vaccines still owned by Mankind Pharma?
Yes. As of 21 October 2026, Bharat Serums and Vaccines is still owned by Mankind Pharma. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Mankind Pharma Limited Annual Report 2025-26 — Mankind Pharma Limited, Annual report; retrieved 21 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.